These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 32486935)
1. Ocular flare-up in patients with systemic lupus erythematosus following discontinuation of hydroxychloroquine. Ebrahimiadib N; Riazi-Esfahani H; Heidari M; Mahmoudi A Lupus; 2020 Jul; 29(8):987-992. PubMed ID: 32486935 [TBL] [Abstract][Full Text] [Related]
2. Acute vision loss in systemic lupus erythematosus: bilateral combined retinal artery and vein occlusion as a catastrophic form of clinical flare. Akhlaghi M; Abtahi-Naeini B; Pourazizi M Lupus; 2018 May; 27(6):1023-1026. PubMed ID: 28853639 [TBL] [Abstract][Full Text] [Related]
3. Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study. Fernandez-Ruiz R; Bornkamp N; Kim MY; Askanase A; Zezon A; Tseng CE; Belmont HM; Saxena A; Salmon JE; Lockshin M; Buyon JP; Izmirly PM Arthritis Res Ther; 2020 Aug; 22(1):191. PubMed ID: 32807233 [TBL] [Abstract][Full Text] [Related]
4. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Tsakonas E; Joseph L; Esdaile JM; Choquette D; Senécal JL; Cividino A; Danoff D; Osterland CK; Yeadon C; Smith CD Lupus; 1998; 7(2):80-5. PubMed ID: 9541091 [TBL] [Abstract][Full Text] [Related]
5. Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report. Ameen Ismail A; Sadek SH; Hatata RM BMC Ophthalmol; 2022 Nov; 22(1):434. PubMed ID: 36376841 [TBL] [Abstract][Full Text] [Related]
6. Bilateral central retinal artery occlusion and vein occlusion complicated by severe choroidopathy in systemic lupus erythematosus. Nishiguchi KM; Ito Y; Terasaki H Lupus; 2013 Jun; 22(7):733-5. PubMed ID: 23681406 [TBL] [Abstract][Full Text] [Related]
7. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Almeida-Brasil CC; Hanly JG; Urowitz M; Clarke AE; Ruiz-Irastorza G; Gordon C; Ramsey-Goldman R; Petri M; Ginzler EM; Wallace DJ; Bae SC; Romero-Diaz J; Dooley MA; Peschken C; Isenberg D; Rahman A; Manzi S; Jacobsen S; Lim S; van Vollenhoven RF; Nived O; Jönsen A; Kamen DL; Aranow C; Sanchez-Guerrero J; Gladman DD; Fortin PR; Alarcón GS; Merrill JT; Kalunian K; Ramos-Casals M; Steinsson K; Zoma A; Askanase A; Khamashta MA; Bruce IN; Inanc M; Abrahamowicz M; Bernatsky S Ann Rheum Dis; 2022 Mar; 81(3):370-378. PubMed ID: 34911705 [TBL] [Abstract][Full Text] [Related]
8. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis. Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896 [TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine in systemic lupus erythematosus (SLE). Ponticelli C; Moroni G Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040 [TBL] [Abstract][Full Text] [Related]
11. Combined retinal artery and vein occlusion in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Durukan AH; Akar Y; Bayraktar MZ; Dinc A; Sahin OF Can J Ophthalmol; 2005 Feb; 40(1):87-9. PubMed ID: 15825539 [No Abstract] [Full Text] [Related]
12. Systemic lupus erythematosus flare-up manifesting as a cilioretinal artery occlusion. el-Asrar AM; Naddaf HO; al-Momen AK; al-Balla SR Lupus; 1995 Apr; 4(2):158-60. PubMed ID: 7795623 [TBL] [Abstract][Full Text] [Related]
13. Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus. Leibovitch I; Goldstein M; Loewenstein A; Barak A Rheumatology (Oxford); 2001 Oct; 40(10):1195-6. PubMed ID: 11600756 [No Abstract] [Full Text] [Related]
14. Case Report: Recurrent retinal vein occlusion as the first clinical manifestation of systemic lupus erythematosus in a male patient. Ben Brahim M; Arfa S; Boubaker F; Chelly J; Ammari W; Hammami S; Arbi F; Berriche O F1000Res; 2021; 10():761. PubMed ID: 35814626 [TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine in lupus pregnancy. Clowse ME; Magder L; Witter F; Petri M Arthritis Rheum; 2006 Nov; 54(11):3640-7. PubMed ID: 17075810 [TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). Costedoat-Chalumeau N; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin du LT; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Tanguy ML; Hulot JS; Lechat P; Musset L; Amoura Z; Piette JC; Ann Rheum Dis; 2013 Nov; 72(11):1786-92. PubMed ID: 23144449 [TBL] [Abstract][Full Text] [Related]
18. Clinical features of ocular damage in systemic lupus erythematosus and risk factors for hydroxychloroquine-related complications. Cheng T; Gu X; Yang Z; Wang C; Chen Y; Zhao X Surv Ophthalmol; 2024; 69(5):733-742. PubMed ID: 38782129 [TBL] [Abstract][Full Text] [Related]
19. Visual Impact of Early Hydroxychloroquine-Related Retinal Structural Changes in Patients with Systemic Lupus Erythematosus. Sallam MA; Beltagi AS; Abdellatif MA; Awadalla MA Ophthalmologica; 2021; 244(4):301-308. PubMed ID: 34015786 [TBL] [Abstract][Full Text] [Related]
20. Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus and anti-phospholipid syndrome. Chang PC; Chen WS; Lin HY; Lee HM; Chen SJ Lupus; 2010 Feb; 19(2):206-9. PubMed ID: 19880552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]